p38 MAPK and MAPK kinase 3/6 mRNA and activities are cellular hypertrophy [1, 2] , increased production of extraincreased in early diabetic glomeruli. cellular matrix protein (ECM) [3, 4] , and decreased proBackground. The p38 mitogen-activated protein kinase
lying signal transduction mechanisms mediating these tially leading to cellular apoptosis and growth. Little is known processes have been less well explored.
about the pattern of glomerular p38 MAPK pathway activation during the course of diabetic nephropathy (DN). We examined Numerous studies reveal protein kinase C (PKC) actithe activity and expression of the p38 MAPK pathway memvation in diabetic glomeruli [7] and in mesangial cells bers, p38 MAPK, MKK3/6, cAMP-responsive element binding cultured under high-glucose conditions [8, 9] . PKC prop- tion, differentiation, and apoptosis [10] [11] [12] .
Results. Glomerular p38 MAPK mRNA expression was significantly higher in DM than C (P Ͻ 0.01) throughout the The MAPK family includes the extracellular signalfour-month period. Western blot revealed an average 3.1-fold regulated kinase-1/2 (ERK1/2) or p42/44 MAPK [12, 13], increase in p38 MAPK protein throughout the study period stress-activated c-Jun N-amino terminal kinase (JNK/ (P Ͻ 0.05). However, p38 MAPK activity was significantly stress-activated protein kinase or SAPK) [11, 12, 14] , increased only in one-and two-month diabetic glomeruli. Glop38 MAPK [15] [16] [17] , and big MAPK (ERK 5) [18] . The merular MKK3/6 and CREB mRNA as well as activity were significantly increased only in one-and two-month DM comclassic MAPK ERK1/2 plays a pivotal role in growth pared with C. MKP-1 mRNA showed a similar pattern.
factor-induced mitogenesis, differentiation, and cellular
Conclusions. Glomerular p38 MAPK activity was increased transformation. ERK1/2 is activated through a Rasin early DN. Parallel to this, we also showed, to our knowledge dependent signal transduction pathway by hormones and for the first time, that there were increased MKK3/6 and CREB activities and mRNA expression. This activated p38 MAPK growth factors. It leads to cellular proliferation and difpathway in diabetic glomeruli may, in part, play a role in the ferentiation by stimulating transcription factors that inpathogenesis of early hypertrophy and extracellular matrix acduce the expression of c-fos and other growth-responsive cumulation.
genes [10, 12, 13] . JNK/SAPK and p38 MAPK represent two independent parallel MAPK pathways that are activated in response to stress signals such as proinflammaThe molecular and cellular mechanisms responsible tory cytokines [11, [14] [15] [16] 19] , ultraviolet irradiation [14] , for diabetic nephropathy (DN) remain incompletely reosmolality changes [15] , and oxidants [20] , leading to solved. While studies indicate involvement of hyperalterations in cell growth, prostanoid production, and glycemia via the stimulation of growth factor-induced other cellular dysfunction [21, 22] . Since hyperosmolality and oxidant stress characterize the diabetic state, p38 MAPK has been posited to medi-under high-glucose conditions [23, 24] . Increased mesangial cell p38 MAPK activity has been identified in associ- 2001 by the International Society of Nephrology ation with high glucose culture conditions [25] and with HCl, pH 6.8, 10% (vol/vol) glycerol]. The lysate was mechanical strain [26] , the latter also activating ERK1/2. centrifuged at 10,000 ϫ g for 10 minutes at 4ЊC, and However, the p38 MAPK pathway has heretofore not the supernatant was stored at Ϫ70ЊC until all rats were been extensively studied in diabetic glomeruli, and little sacrificed. Protein concentrations were determined with is known about time-course changes of MAPK in experia Bio-Rad kit (Bio-Rad Laboratories, Hercules, CA, mental DN in vivo. Furthermore, there are no reports USA). Aliquots of 50 g protein were treated with regarding the regulation of the upstream kinase activators Laemmli sample buffer, heated at 100ЊC for five minutes, of p38 MAPK, namely MKK3/6 under diabetic conditions. electrophoresed, and transferred to Hybond-ECL memThis study examined the p38 MAPK pathway in globranes (Amersham Life Science, Inc., Arlington Heights, meruli isolated from streptozotocin-induced diabetic rats IL, USA). Blocked membranes were incubated overone, two, three, and four months after diabetes induction.
night at 4ЊC with a 1:1000 dilution of polyclonal antibody Besides p38 MAPK, we also studied (1) MKK3 and to p38 MAPK, phospho-specific p38 MAPK, phospho-MKK6, which are upstream activators of p38 MAPK specific MKK3/6, or phospho-specific CREB (New En- [27, 28] ; (2) Microdissection, total RNA extraction, and the activities of these key signaling kinases and target reverse transcription transcription factor, but also their mRNA expression Glomerular microdissection, total RNA extraction, during the course of DN. We also correlated these with and reverse transcription (RT) were performed as dethe expression of fibronectin and transforming growth scribed recently [33] . factor-␤ (TGF-␤), key markers of DN.
Semiquantitative competitive PCR METHODS
Competitor cDNAs were used as internal standards Animals in semiquantitative PCR evaluation of GAPDH, p38 All animal studies were conducted under an approved MAPK, MKK3, MKK6, CREB, fibronectin, MKP-1, and institutional protocol. Sprague-Dawley rats weighing 220 TGF-␤ mRNAs. Each competitor was designed to conto 250 g were injected intraperitoneally with either dilutain the same base-pair sequence as the target cDNA, ent [N ϭ 16, control (C)] or 65 mg/kg streptozotocin but had a portion deleted so that the competitor PCR-(STZ) [N ϭ 16, diabetes (DM)]. Blood glucose levels generated fragment could be easily distinguished electrowere measured on the third day after STZ injection to phoretically by size. The primers used are summarized confirm the development of diabetes. Rats were housed in Table 1 . cDNA from 1/10 of a glomerulus per reaction in a temperature-controlled room and were given free tube was used for GAPDH and fibronectin, 1/5 of a access to water and standard laboratory chow during the glomerulus for p38 MAPK, and 1/2 glomerulus for the four-month study period. Four rats from each group were remainder. PCR was performed using the test or wildsacrificed at the end of one, two, three, or four months.
type cDNA, Taq-Gold polymerase (1.5 U for GAPDH, Sieved glomeruli obtained from the one-to four-month p38 MAPK, and fibronectin; 2.5 U for the remainder), rats were used for Western blots, while microdissected 20 mol/L dNTP, sense and antisense primers (25 pmol glomeruli from the one-, two-, and four-month rats were for GAPDH, p38 MAPK, and fibronectin; 30 pmol for used for RNA extraction and polymerase chain reactions the remainder), and specific dilution of competitor in a (PCRs). Blood glucose levels of the control rats at one, volume of 50 L containing 1 ϫ PCR buffer. The PCR two, three, and four months were as follows: 103.1 Ϯ 4.5, conditions were denaturation at 95ЊC for 45 seconds, 106.5 Ϯ 2.4, 102.2 Ϯ 4.8, 95.4 Ϯ 3.8, and 104.5 Ϯ 6.9, annealing at corresponding temperature for 45 seconds, respectively. Blood glucose levels in the diabetic rats and extension at 72ЊC for two minutes (Table 1) . Initial were 438.8 Ϯ 18.6 at three days post-STZ, 453.0 Ϯ 18.8
heating at 95ЊC for nine minutes and final extension at at one month, 441.4 Ϯ 23.2 at two months, 447.5 Ϯ 15.2 72ЊC for seven minutes was performed for all PCRs. The at three months, and 494.3 Ϯ 17.8 at four months.
RT-PCR products were separated by electrophoresis.
Western blot analysis
Band densities were analyzed by laser densitometry (Helena Laboratories, Beaumont, TX, USA), and the Sieved rat glomeruli were lysed in sodium dodecyl sulfate (SDS) sample buffer [2% SDS, 10 mmol/L Trisratio of wild type to competitor was used for analyses. 
Statistical analysis isoforms, lower panel)
. Interestingly, phospho-specific p38 MAPK levels, which represent p38 MAPK activity, All values are expressed as the mean Ϯ SEM. Statistiwere greater in the diabetic rats relative to the correcal analysis was performed using the statistical package sponding control rats at one and two months (P Ͻ 0.01 SPSS for Windows version 7.51 (SPSS, Inc., Chicago, IL, at each time), but decreased to control levels thereafter. USA). Results were analyzed using the Student t test or
In contrast, although total p38 levels (lower panel) were analysis of variance (ANOVA) for multiple comparisons.
unchanged from one to four months in each group alone, they were significantly elevated (3-fold) in the diabetic RESULTS glomeruli compared with control at all four time points (P Ͻ 0.05). The ratios of phospho-p38 to total p38 MAPK A time-course study was performed wherein the activities as well as mRNA expression were simultaneously levels were significantly greater in DM glomeruli only at one and two months (P Ͻ 0.01). Equal protein loading examined of p38 MAPK, MKK3/6 (upstream activators of p38 MAPK), and CREB, in addition to MKP-1 was confirmed by Coomassie Blue staining of the gel.
To evaluate whether this increase in p38 MAPK exmRNA in glomeruli isolated from control rats versus rats that had been diabetic for one to four months. To pression in DM glomeruli was also regulated at the mRNA level, total RNA from microdissected glomeruli correlate these parameters to the progression of DN, mRNA expression of the key ECM protein fibronectin from the one-, two-and four-month study were used. We developed a new competitive PCR using primers as well as transforming growth factor-␤ (TGF-␤) also were evaluated.
derived from the sequence of rat p38 MAPK [15] . The p38 MAPK mRNA ratios (wild-type:competitor) were p38 MAPK activity, protein, and mRNA expression significantly greater in DM rats than the corresponding C and were over twofold greater at all three time points We first examined whether p38 MAPK activity, protein, as well as mRNA expression were altered in the studied (Fig. 2) . In contrast, glomerular GAPDH mRNA ratios (wild-type:competitor) in the DM glomeruli did one-to four-month time period after STZ injection. Figure 1 shows a representative Western blot of equal not differ from those in the C group (data not shown). p38 MAPK mRNA ratios remained significantly higher amounts of protein from lysates of sieved glomeruli from the control and DM rats at one to four months. The blot in DM relative to corresponding C after correction for GAPDH mRNA ratios (Fig. 3 ). was first probed with an antibody to phospho-specific p38 MAPK (upper panel), stripped, and then probed Thus, total p38 MAPK protein and mRNA expression are increased in experimental DN, but a new level of with an antibody that recognizes total p38 MAPK (all Fig. 1 . Western blot of glomerular total and phospho-specific p38 mitogen-activated protein kinase (MAPK) in control and diabetic (DM) rats (representative of four blots). Total p38 MAPK protein expression (lower panel) was significantly higher in DM than control throughout the four months (average 3.1-fold increase by densitometry, P Ͻ 0.05). On the other hand, activated phospho-specific p38 MAPK protein (upper panel) showed a significant increase only in one-and two-month DM glomeruli (P Ͻ 0.001). regulation of p38 MAPK enzyme activity is operative in relative to control, but not thereafter (1.8-and 2.1-fold increments at one and two months, respectively, P Ͻ the early versus later stages of DN.
0.05). This trend was similar to phospho-specific p38 MKK3/6 activity and mRNA expression MAPK (Fig. 1, upper panel) .
Since DM seemed to up-regulate MKK3/6 activity, we The activity and mRNA expression of the upstream kinase activators of p38 MAPK, namely, MKK3/6, were wanted to determine whether this was related to mRNA expression. Here again, we successfully developed a examined. The blot shown in Figure 1 was stripped and reprobed with an antibody that recognizes both phosspecific competitive PCR approach to evaluate MKK3 and MKK6 mRNA levels. Glomerular MKK3 as well as pho-specific MKK3 and MKK6 (activated forms of these kinases). This representative Western blot seen in Fig-MKK6 mRNA ratios (wild-type:competitor) were significantly higher in the one-and two-month DM rats comure 4 shows that phospho-specific MKK3/6 levels were also increased in one-and two-month diabetic glomeruli pared with corresponding C rats, but unlike p38 MAPK mRNA expression at one and two months, respectively (Fig. 8) . These results show for the first time that increased CREB activity in early DN may be a consequence of increased activity of its upstream kinase activators as well as increased CREB mRNA expression.
MKP-1 mRNA expression
To determine whether the fall in p38 MAPK and MKK3/6 activities in later time periods was due to the action of a phosphatase, the expression of MKP-1 mRNA also was examined by competitive PCR. Glomerular MKP-1 mRNA ratios (wild-type:competitor) were significantly greater in DM versus C only at one and two months, Fig. 3 . Glomerular p38 MAPK mRNA ratio:GAPDH mRNA ratio of but not at four months, both before (data not shown) the rats. Ratio equals the optical density of wild-type band to the optical and after correction for GAPDH ratios (Fig. 9) . Hence, density of the competitor band. p38 MAPK mRNA ratios were then the fall-off in kinase activities after two months could corrected for the GAPDH mRNA ratio. These ratios were significantly higher in DM compared with corresponding control rats throughout not be attributed to changes in MKP-1 mRNA levels. 
Fibronectin and TGF-␤ mRNA expression
To correlate these observations to evolving DN, the mRNA expression of the key matrix protein, fibronectin, as well that of the growth factor, TGF-␤, were examined mRNA, the MKK3/6 mRNAs returned to control levels at four months. After correcting for GAPDH mRNA using semiquantitative competitive PCR. The glomeruratios in each sample, there remained a significant, nearly lar fibronectin mRNA ratio (wild-type:competitor) was twofold increase in MKK3 and MKK6 mRNAs at onesignificantly higher in the DM relative to the correspondand two-month time periods, but not at four months ing C rats throughout the four-month period before (data (Figs. 5 and 6) .
not shown) and after correction for GAPDH mRNA These results demonstrate, to our knowledge for the levels (P Ͻ 0.005; Fig. 10 ). first time, the regulation of MKKs under diabetic condiSimilarly, glomerular TGF-␤ mRNA ratios (wild-type: tions, and also suggest a new level of potential transcripcompetitor) were significantly greater in the DM rats tional regulation of p38 MAPK family signaling molerelative to corresponding C rats throughout the fourcules in DN. month period before (data not shown) and after correction for GAPDH mRNA levels (P Ͻ 0.01; Fig. 11 ).
CREB activity and mRNA expression
Thus, glomerular mRNA levels of all the factors examTo determine whether activation of the p38 MAPK ined, p38 MAPK, MKK3/6, CREB, MKP-1, fibronectin, pathway could induce parallel increases in the activity and TGF-␤ (except the GAPDH control), were signifiof a p38 MAPK target transcription factor, we examined cantly higher in DM compared with C rats at one and the activity and mRNA expression of CREB due to two months after STZ or diluent injections, respectively. its role in fibronectin transcription [34, 35] . Glomerular This suggests a p38 MAPK-regulated mechanism leading protein lysates were subjected to immunoblotting using to fibronectin expression in early DN. However, a more an antibody to phospho-specific (activated) CREB. The complex pattern emerges by three to four months, with representative blot in Figure 7 shows that CREB activity increased p38 MAPK mRNA and protein expression was significantly increased in the one-and two-month (without corresponding p38 MAPK activity), normaliza-DM samples relative to C (P Ͻ 0.005). However, similar tion of mRNAs and activities of MKK3/6 and CREB, to p38 MAPK and MKK3/6 activities, CREB activity and nevertheless, the maintenance of increased fibroalso declined at three and four months.
nectin and TGF-␤ mRNA expression. We then developed a specific competitive PCR technique to evaluate CREB mRNA levels. Glomerular CREB DISCUSSION mRNA ratios (wild-type:competitor) were greater in the Diabetic nephropathy is characterized by glomerular DM glomeruli compared with C at one and two months, hypertrophy and ECM accumulation [36, 37] . Since p38 but not at four months. This trend was parallel to that MAPK is activated by cellular stressors and has been observed with MKK3/6 mRNAs, but different from p38 implicated in the pathogenesis of cardiac and vascular MAPK mRNA, which remained elevated even at four smooth muscle cell hypertrophy [38, 39] , TGF-␤-induced months. After correcting for GAPDH mRNA ratios, there were significant 1.7-and 1.8-fold increases in CREB gene expression and TGF-␤ formation [40, 41] , we fo- There was a significant increase in MKK6 mRNA in one-and twoGlomerular MKK3 mRNA expression was significantly higher in onemonth DM rats compared with corresponding control rats. Symbols and two-month DM rats than in corresponding control rats and returned are: (ᮀ) 1 month; ( ) 2 months; ( ) 4 months; *P Ͻ 0.05 vs. control. to control level after four months. Symbols are: (ᮀ) 1 month; ( ) 2 months; ( ) 4 months; *P Ͻ 0.05 vs. control. MKK3 mRNA expression showed a similar pattern as the phospho-specific MKK3/6 protein expression (Fig. 4) . [23] . Other in vitro studies also demonstrated that shortterm exposure to high glucose activated p38 MAPK in cultured rat vascular smooth muscle cells [24] and mesancused on the p38 MAPK pathway rather than other gial cells [25] . However, not all investigators report inMAPKs to discern the effector pathways that may medicreased p38 MAPK activity in cultured mesangial cells ate DN. We demonstrate, to our knowledge for the first treated with high glucose [42] . These inconsistent findtime, that glomerular p38 MAPK activity is increased ings may result from different culture conditions and/or in early DN and that the activation of p38 MAPK is glucose concentrations utilized in these experiments. In associated with and likely due to increased MKK3 and our current study, we observed increased p38 MAPK MKK6 at the mRNA and activity levels.
protein expression as well as activity in early diabetic p38 MAPK is a member of the MAPK family and is glomeruli, a finding that is consistent with the aforemenknown as a "stress-activated kinase" along with the JNK tioned study in diabetic aorta [23] . [14] [15] [16] [17] . p38 MAPK is strongly activated by environmen-
The activity of the MAPK family including p38 MAPK tal stressors, including osmolality changes [15] , oxidants is determined by a dynamic balance between phosphory-[20], and proinflammatory cytokines [19] , leading to lation and dephosphorylation, resulting from dual specific cellular growth, differentiation, and apoptosis [21, 38] .
protein kinases (MAPK kinase, MKK, or MEK) and phosRecent work has shown that high ambient glucose conphatase, respectively [27, 28, 32] . Among numerous MAPK centrations increased p38 MAPK activity in cultured vaskinases, MKK3 and MKK6 catalyze the phosphorylation cular smooth muscle cells via PKC-dependent and -indeof p38 MAPK specifically and MKK4/SEK1 mediates pendent pathways [23, 24] . Increased p38 MAPK protein the activation of both p38 MAPK and JNK [27, 28] . MKK3 and/or MKK6 are activated by factors such as and activity were also observed in aortas of diabetic rats Fig. 7 . Western blot of glomerular phospho-specific cAMP-responsive element binding protein (CREB) in control and DM rats (representative of three blots). Phospho-CREB levels were significantly higher in the one-and two-month DM glomeruli than in the corresponding control glomeruli (P Ͻ 0.005). Fig. 8 . Glomerular CREB mRNA ratio:GAPDH ratio of the rats. Fig. 10 . Glomerular fibronectin mRNA ratio:GAPDH ratio of the rats. CREB mRNA expression at one and two months was significantly Fibronectin mRNA expression was significantly increased in DM comhigher in DM than control rats, but at four months, there was no pared with corresponding control glomeruli throughout the four-month significant difference between the two groups. Symbols are: (ᮀ) 1 study period. Symbols are: (ᮀ) 1 month; ( ) 2 months; ( ) 4 months; month; ( ) 2 months; ( ) 4 months; *P Ͻ 0.05 vs. control. *P Ͻ 0.005 vs. control. Fig. 9 . Glomerular MKP-1 mRNA ratio:GAPDH ratio of the rats. Fig. 11 . Glomerular transforming growth factor-␤ (TGF-␤) mRNA ratio:GAPDH ratio of the rats. Glomerular TGF-␤ mRNA expression MAPK phosphatase-1 (MKP-1) mRNA expression was significantly higher in one-and two-month DM than corresponding control rats.
was significantly increased in DM rats compared with corresponding control rats throughout the four-month study period. [23, 25] , little is [19, 27, [29] [30] [31] [53] [54] [55] . In addition to these factors, the p38 MAPK also activates other protein kinases. Among these known about the upstream activators of p38 MAPK in this setting. Haneda et al observed activation of MEK1, downstream kinases, mitogen-and stress-activated protein kinase-1 (MSK-1), MAPK-activated protein kinase-2 an upstream protein kinase of ERK1, in diabetic glomeruli and mesangial cells under high glucose conditions, (MAPKAPK-2), and ribosomal S6 kinase-B (RSK-B) have been implicated in the phosphorylation of CREB but did not assess the p38 MAPK pathway [45] . Our study demonstrates, for the first time to our knowledge, after activation by the p38 MAPK pathway [30, 31] . CREB can lead to gene expression by binding to the that MKK3 and MKK6 activity as well as mRNA expression is increased in early diabetic glomeruli, presumably cAMP response element (CRE). Since the fibronectin promotor contains a CRE located Ϫ170 bp [56] , actiresulting in p38 MAPK activation. We also show for the first time that p38 MAPK mRNA expression is increased.
vated CREB can bind to this CRE, leading to fibronectin mRNA expression. Kreisberg et al have demonstrated Mitogen-activated protein kinase phosphatase-1 is a member of the rapidly growing, dual-specific protein tythat activation of PKC by high glucose plus TGF-␤ or phorbol 12 myristate 13-acetate (PMA) induced CREB rosine phosphatase family that dephosphorylates and inactivates various members of the MAPK family [32, 46] . activation and fibronectin transcription in mesangial cells in vitro [34] . Nahman et al have demonstrated the Initial reports regarding MKP-1 demonstrated that MKP-1 was associated with ERK both in vivo and in vitro [46] , involvement of CRE elements in angiotensin II-induced fibronectin expression in mesangial cells [35] . We now but recent investigations suggest that MKP-1 exhibits a broad substrate specificity, being able to inactivate both report increased fibronectin mRNA expression along with increased CREB mRNA and activity in early dia-JNK and p38 MAPK [20, 44] . MPK-1 is principally regulated at the transcriptional level [47] , as evidenced by betic glomeruli in vivo.
In these experiments, the p38 MAPK pathway was very low to undetectable mRNA expression in quiescent cells and a rapid induction by multiple signaling molefunctionally activated in early diabetic glomeruli but returned to the control levels with time, a new in vivo cules, including growth factors and angiotensin II [32, 46, [48] [49] [50] [51] [52] . Most previous in vitro studies have suggested finding that is in agreement with most previous in vitro studies. Although the mechanism of this deactivation at that MKP-1 is implicated in a feedback loop serving to inactivate MAPK after stimulation by mitogens or later time periods is presently unclear, it seems that more proximal signal transduction molecules than MKK3 and cellular stress [20, 50] .
Even though high glucose is known to exert cellular MKK6 may be involved. Glomerular fibronectin mRNA expression was increased not only in early diabetic rats stress, the effect of hyperglycemia on MKP-1 expression remains controversial. An in vitro study of vascular smooth but also after three months, even when the p38 MAPK pathway was already deactivated. These findings suggest cells revealed that 12 to 24 hours of incubation in high glucose (25 mmol/L) decreased MKP-1 mRNA and prothat fibronectin mRNA expression is not totally dependent on the MKK3/6-p38MAPK-CREB axis. TGF-␤ is tein [51] . MKP-1 protein expression was also suppressed in mesangial cells grown under high glucose (30 mmol/L) known to play an important role in the synthesis of ECM molecules in DN [57, 58] . Previous studies have demonfor five days, resulting in activation of ERK [52] . However, Kang et al observed that MKP-1 protein was instrated that TGF-␤ activates at least two independent pathways, the TGF-␤-activated kinase 1 (TAK1)-MKK6-creased in mesangial cells after one hour of exposure to high glucose (40 mmol/L), sustained for 24 hours, and p38MAPK pathway and the Smad-mediated pathway [59, 60] . Even though TGF-␤ activates the p38 MAPK declined to control levels after 48 hours [25] . The reasons for the discrepant effects of high glucose on MKP-1 are pathway, a recent study showed that dominant negative TAK1 or dominant negative MKK6 fails to inhibit TGFunclear, but may result from differences in cell type, use of pooled samples, duration of high glucose exposure, ␤-induced signal transduction in C2C12 myoblast cells due to an intact Smad-mediated pathway [40] . In our and glucose concentrations used. Our study found that the time course of glomerular MKP-1 mRNA expression study, glomerular TGF-␤ mRNA expression was significantly higher in DM rats compared with C rats throughcoincided with activation of p38 MAPK. These results implicate MKP-1 induction in early diabetic glomeruli out the four-month study period similar to fibronectin. This suggests that an intact TGF-␤-Smad pathway may as a negative feedback loop to dephosphorylate activated MAPK including p38 MAPK, rather than a pathogenetic mediate the sustained increase in fibronectin mRNA after three to four months when the MKK3/6-p38 mechanism for p38 activation.
Once p38 MAPK is activated, it phosphorylates sev-MAPK-CREB pathway is already deactivated. In summary, p38 MAPK activity was increased in early eral transcription factors at serine and threonine residues including CREB and activating transcription factor-1 diabetic glomeruli, and this increase was associated with inciding with the p38 MAPK activity. This activated p38 [726] [727] [728] [729] [730] [731] [732] [733] [734] [735] 1995 MAPK pathway in diabetic glomeruli may, in part, play 13 . Cobb MH, Robbins DJ, Boulton TG: ERKs, extracellular signala role in the pathogenesis of early hypertrophy and extra-
